• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
  • Contact Us
WeedWeek

WeedWeek

WeedWeek is the best way to keep up with the green rush

  • Membership
  • My Account
  • LinkedIn
  • Instagram
  • Twitter
  • Politics
  • Money
  • Ops
  • Brands
  • Culture
  • Events

CBD SHOWS PROMISE AS AN ANTIBIOTIC

By Alex Halperin
07/01/2019 09:11 AM GMT-0700
FacebookTweetPin

A new study found CBD is “remarkably effective” at killing bacteria. In test tubes CBD showed promise for its ability to kill bacteria which have shown resistance to other drugs as well as staph and strp.
Live Science

  • The researchers caution the results are preliminary and emphasize people should not use CBD to treat infections.

Stat reports the booming popularity of CBD is becoming a dilemma for doctors.

  • The question they confront is, “Should they encourage a treatment that may not work but also may not hurt their patients, if it gives them hope? Or should they reject any treatment out of hand that hasn’t been proven effective?”
  • Doctors who go ahead with it have questions about dosing, where to find safe product and how to determine if it’s effective treatment.

Quick Hit

  1. The growing prevalence of CBD-infused products may force the FDA to regulate them.
    Washington Post
  2. The Economist says MED won’t solve the opioid crisis.
  3. Abercrombie & Fitch will start selling CBD products.
    CNBC

[gravityform id="5" title="true" description="false" ajax="true" tabindex=""]
Share:
FacebookTweetPin
Filed Under:
Federal

Primary Sidebar

Recent Webinar

Growth in a Tight Market

WeedWeek Wonks: 2025 Wrap-Up & 2026 Outlook

Duration Broadcast Jan 22
Speakers Elisabeth Stahura, Alex Halperin

Watch Now

Join WeedWeek California Pro Today!

WeedWeek Pro is the essential news and information resource for California cannabis professionals.

  • Access the Weedweek California Pro Newsletter
  • Access the California Tax and License Maps
  • Steep discounts on job posts in the WeedWeek career center
Sign Up

Get a risk-free 14 day trial for FREE!

Most Read

  • Regulation & Compliance

    EXCLUSIVE: We tested top Calif. prerolls for potency inflation

  • Industry Voices

    Calif. interstate commerce law opens pathway for licensed operators

  • Regulation & Compliance

    Exclusive: Does Stiiizy have a diiiversiiion problem?

Related Articles

See More Federal Articles
Trump
Federal

Newsbrief: Trump’s rescheduling order splits GOP

hemp
Hemp

Newsbrief: Sen. Rand Paul visits Cornbread hemp

supreme court
Federal

Newsbrief: Supreme Court passes on legalization case

Become a member and get access to exclusive content.

Join Now!

Footer

Join WeedWeek Pro

Become A Member Today and Get Access to Exclusive Content. Join here

Follow us

Follow WeedWeek for more content.

  • Instagram
  • LinkedIn
  • Twitter
  • About
  • Privacy Policy
  • Terms & Conditions
  • Contact
  • Advertise

RegStream Media Group © 2026. All Rights Reserved